Emerging Biopharma (EBP) launches have been challenging and will continue to be due to numerous factors. In light of that, companies must change how they prepare for launch with new focus on three key pillars:

1. Patient journey insights and strengthening
2. HCP engagement optimization
3. Integrated evidence and value strategy

In this webinar, we will focus on the 2nd pillar, namely on Customer Engagement, particularly around technology capabilities needed to enable new commercial models and successful launches.

Key Takeaways:

• Commercialization infrastructure cannot, on its own, ensure a successful product launch, but alternately, suboptimal decisions can delay or derail it. Learn how proper planning can help with this process.
• Having a clean slate for technology choices can appear daunting, but should be viewed as a great opportunity to establish a solid set up from the get-go that can evolve with the company’s needs.
• Understand what success looks like and key steps to achieve it.

Speakers:

Mihales Karasavas
COEUS Solutions

Adam Silvis
Technology Client Partner, IQVIA

Aleksandra Ilic
VP – Solutions, FFO COE, IQVIA